Bringing Cuba’s Lung Cancer Vaccine to the States
Guest Post by Kelvin Lee, MD Roswell Park Cancer Institute
Guest Post by Kelvin Lee, MD Roswell Park Cancer Institute
Guest Post by Barbara A. Conley, MD National Cancer Institute (NCI)
AACR membership includes scientists and physicians from across the cancer research enterprise. Whether basic, translational, or clinical researchers, they...
This year, at the AACR Annual Meeting held in Philadelphia April 18 to 22, an astounding 19,300 members of...
Game-changing modern cancer therapies—immunotherapies and targeted therapies, among others—have been providing promising treatment outcomes in the recent years. The...
Guest Post by Toni Kay Mangskau Mayo Clinic Cancer Center
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
With the late-breaking and clinical trial-placeholder abstract deadlines a week away, we thought it was a good time to...
Adding the PI3-kinase inhibitor pictilisib to fulvestrant doubled progression-free survival for some women with advanced hormone-receptor positive breast cancer,...
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope...